Related articles
-
NewsHorizon Awards 2026: Professor James Ebdon named as winner of John Snow Prize
Environmental microbiologist Professor James Ebdon, from the University of Brighton, UK, has been named as the winner of the John Snow Public Health Innovation Prize, which recognises outstanding achievements in applied microbiology that deliver measurable improvements in public health and environmental health outcomes.
-
NewsAMI members call for microbiome-focused approach to EU biotechnology regulation
Members of Applied Microbiology International (AMI) have urged the European Commission to put microbial communities at the heart of environmental risk assessments for genetically modified microorganisms, as part of its response to the EU Biotech Act consultation.
-
NewsBacteria-powered biocomputer tackles complex problems in parallel
Researchers have built a biocomputer that uses growing bacteria to explore many possible solutions at the same time. By guiding the microbes through microfluidic networks, the system could offer a resource-efficient way to tackle complex problems in areas such as molecular biology, encryption and AI.
More from News
-
NewsSingle-copy genes could improve identification of closely related Vibrio species
A new genetic approach could make it easier to distinguish closely related Vibrio species and estimate how abundant they are in environmental samples. Researchers found that single-copy genes can provide higher resolution than the widely used 16S rDNA marker, which often struggles to separate highly similar bacteria.
-
NewsEnzyme found to have surprising role in earliest infant gut microbiome development
Microbiologists have found that an enzyme, not normally associated with microbial activities in the human gut, to have a role in how some bacteria access key nutrients in breast milk. The findings, published in Nature Communications today (Monday 2 November), provides a new understanding about feeding preferences ...
-
NewsWho actually benefits from H. pylori treatment? A genetic score can tell before the first pill
In two Chinese randomized trials, a genetic score built from 11 variants identified people whose gastric cancer risk fell 56%–80% after Helicobacter pylori eradication — cutting the number needed to treat from 112 to 43.
No comments yet